Monique Dail
8PUBLICATIONS
64CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Dec 10, 2025
Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study.Rakesh Popat, Meral Beksac, Meletios A Dimopoulos
|Aug 25, 2022
Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and Azacitidine.Daniel A Pollyea, Keith W Pratz, Andrew H Wei
|Aug 01, 2022
Disruption of stem cell niche-confined R-spondin 3 expression leads to impaired hematopoiesis.Antonina V Kurtova, Melanie Heinlein, Simon Haas
|Jul 18, 2022
Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia.Naval Daver, Alexander E Perl, Joseph Maly
|Dec 21, 2021
Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome.Aaron T Gerds, Bart L Scott, Peter Greenberg
|Dec 15, 2021
Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine.Keith W Pratz, Brian A Jonas, Vinod Pullarkat
Pageof 2
Frequent Collaborators
2 joint publications
Daniel A Pollyea
2 joint publications
Brenda Chyla
2 joint publications
Courtney D DiNardo
2 joint publications
Christian Recher
2 joint publications
Brian A Jonas
2 joint publications
Keith W Pratz
1 joint publications
Anica M Wandler
1 joint publications
Anneleen Daemen
1 joint publications
Jasmine C Wong
1 joint publications
Jinghui Zhang
